跳至主要内容
临床试验/CTRI/2024/09/073351
CTRI/2024/09/073351尚未招募2 期

SINGLE CENTRIC NON RANDOMIZED OPEN CLINICAL TRIAL PHASE II IN DEEPANA SILATHUMA NOI (DYSLIPIDEMIA) WITH SIDDHA MEDICINE PIRANDAI VADAGAM AMONG PATIENTS ATTENDING OPD AT GOVERNMENT SIDDHA MEDICAL COLLEGE HOSPITAL CHENNAI

Dhildhar T1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年9月9日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Normal in lipid profile assessed by blood investigation.

研究概览

简要总结

Dyslipidemia is a very common lifestyle disorder.Dyslipidemia can have a number of clinical consequences, most notably premature atherosclerotic cardiovascular disease (ASCVD), and therefore important to appropriately diagnose and treat. In the siddha system of medicine Dyslipidemia is treated with a unique combination of medicine PIRANDAI VADAGAM which will be cost effective and reliable.The aim of this study is the management Deepana Silathuma Noi (Dyslipidemia)  with the Siddha medicine PIRANDAI VADAGAM  and the objective is to determine the therapeutic efficacy and safety profile of the Siddha medicine PIRANDAI VADAGAM in the treatment of Deepana Silathuma Noi (Dyslipidemia). As the literary evidences support the usage of drugs in the disease, hypothesis is created in such a way that the efficacy of PIRANDAI VADAGAM will be a better solution for the management of Deepana Silathuma Noi (Dyslipidemia)

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients who have derangement in lipid profile.

排除标准

  • Patients who have history of pancreatitis, hypothyroidism, IHD, Stroke.

结局指标

主要结局

Normal in lipid profile assessed by blood investigation.

时间窗: The outcome will be assessed with in 12 weeks

次要结局

  • Normal in BMI will be assessed as secondary outcome.(Outcome may be expected in a period 12 weeks)

研究者

发起方
Dhildhar T
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dhildhar T

Government Siddha Medical College

研究点 (1)

Loading locations...

相似试验